Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:1504-1514
doi: 10.1161/CIRCULATIONAHA.106.670885
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, L. B.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Emergency treatment of Stroke
Right arrow Anticoagulants
Right arrow Antiplatelets
Right arrow Neuroprotectors
Right arrow Thrombolysis
Right arrow Other Stroke Treatment - Medical

(Circulation. 2007;116:1504-1514.)
© 2007 American Heart Association, Inc.


Contemporary Reviews in Cardiovascular Medicine

Acute Ischemic Stroke Treatment in 2007

Larry B. Goldstein, MD

From the Department of Medicine (Neurology), Center for Cerebrovascular Disease, Center for Clinical Health Policy Research, Duke University and Durham VA Medical Center, Durham, NC.

Correspondence to Larry B. Goldstein, MD, Box 3651, Duke University Medical Center, Durham, NC 27710. E-mail golds004@mc.duke.edu


Key Words: stroke • anticoagulants • blood pressure • complications • imaging • thrombolysis • antiplatelets


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
A variety of interventions have proven effective in reducing the risk of a first stroke.1 Nevertheless, each year, more than 700 000 Americans have strokes and more than 150 000 die, making stroke the country’s third-leading cause of death.2 More than 25% of stroke survivors older than age 65 years are disabled 6 months later.2 On the basis of the results of prospective randomized clinical trials and other studies performed over the past decade, the general approach to the management of acute stroke has evolved from nihilism to active intervention.


*    Principles of Management
 
A large volume of experimental studies delineates the various aspects of the ischemic cascade. The results of the single laboratory study shown in Figure 1 provide a conceptual framework that guides the current clinical approach to patients with acute ischemic stroke.3 The experiment, performed in awake monkeys, shows that focal symptoms (in this case, paralysis) develop when local cerebral blood flow drops below a certain threshold (in this experiment, <23 mL · 100 g–1 · min–1). In Figure 1, the hatched area between the development of symptoms and infarction is a graphic representation of the so-called penumbra, an area of brain that is functionally inactive but structurally intact and potentially salvageable. Neurological function is completely recoverable if local cerebral blood flow is restored promptly. For a given level of reduced blood flow, the likelihood of sustaining irreversible injury (ie, ischemic stroke) increases as a function of time. This essential biology is the basis of the mantra, "Time lost . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
R.-J. J.H.M. Miserus, M. V. Herias, L. Prinzen, M. B.I. Lobbes, R.-J. Van Suylen, A. Dirksen, T. M. Hackeng, J. W.M. Heemskerk, J. M.A. van Engelshoven, M. J.A.P. Daemen, et al.
Molecular MRI of Early Thrombus Formation Using a Bimodal {alpha}2-Antiplasmin-Based Contrast Agent
J. Am. Coll. Cardiol. Img., August 1, 2009; 2(8): 987 - 996.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. K. Reddy and V. Labhasetwar
Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury
FASEB J, May 1, 2009; 23(5): 1384 - 1395.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Lu, J.-Q. Chen, G.-P. Zhou, S.-H. Wu, Y.-F. Guan, and C.-S. Yuan
Multimolecular complex of Par-4 and E2F1 binding to Smac promoter contributes to glutamate-induced apoptosis in human- bone mesenchymal stem cells
Nucleic Acids Res., September 1, 2008; 36(15): 5021 - 5032.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The year in interventional cardiology.
J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2355 - 2369.
[Full Text] [PDF]